Gossamer Bio (GOSS) Invested Capital (2022 - 2025)
Gossamer Bio's Invested Capital history spans 4 years, with the latest figure at -$122.8 million for Q4 2025.
- For Q4 2025, Invested Capital fell 154.08% year-over-year to -$122.8 million; the TTM value through Dec 2025 reached -$122.8 million, down 154.08%, while the annual FY2025 figure was -$122.8 million, 154.08% down from the prior year.
- Invested Capital reached -$122.8 million in Q4 2025 per GOSS's latest filing, down from -$82.3 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $301.0 million in Q3 2023 to a low of -$122.8 million in Q4 2025.
- Average Invested Capital over 4 years is $131.3 million, with a median of $193.3 million recorded in 2022.
- Peak YoY movement for Invested Capital: skyrocketed 722.51% in 2024, then tumbled 154.08% in 2025.
- A 4-year view of Invested Capital shows it stood at $207.8 million in 2022, then increased by 24.82% to $259.4 million in 2023, then fell by 12.47% to $227.0 million in 2024, then crashed by 154.08% to -$122.8 million in 2025.
- Per Business Quant, the three most recent readings for GOSS's Invested Capital are -$122.8 million (Q4 2025), -$82.3 million (Q3 2025), and -$46.1 million (Q2 2025).